According to ORIC Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.97. At the end of 2024 the company had a P/S ratio of N/A.
Year | P/S ratio | Change |
---|---|---|
2024 | N/A | |
2023 | N/A | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A |